Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Arcutis Biotherapeutics
Arcutis Biotherapeutics
(ARQT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zoryve
Roflumilast
2022-07-29
2023-2037
Chronic obstructive pulmonary disease
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Roflumilast
lymphoma
,
healthy volunteers/patients
,
b-cell lymphoma
,
alzheimer disease
,
neuronal plasticity
,
large b-cell lymphoma diffuse
,
schizophrenia
,
memory disorders
,
hematologic neoplasms
,
neoplasms
,
b-cell chronic lymphocytic leukemia
,
brain diseases
,
leukemia
,
hematopoietic stem cell transplantation
,
cell- and tissue-based therapy
,
adoptive immunotherapy
,
lymphocyte transfusion
,
diabetes mellitus
,
syndrome
,
dementia
,
fibrosis
,
inflammation
,
non-alcoholic fatty liver disease
,
fatty liver
,
depression
,
major depressive disorder
,
depressive disorder
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
amnesia
,
cognitive dysfunction
,
cognition disorders
,
nervous system diseases
,
polyostotic fibrous dysplasia
,
overweight
,
metabolic syndrome
,
cerebrovascular disorders
,
memory
,
recovery of function
,
rosacea
,
fragile x syndrome
,
psoriasis
,
asthma
,
dermatitis
,
atopic dermatitis
,
bronchiectasis
,
type 2 diabetes mellitus
,
seborrheic dermatitis
,
peripheral nervous system diseases
,
prediabetic state
,
diabetic nephropathies
,
kidney diseases
,
respiratory signs and symptoms
,
diabetic neuropathies
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
lung diseases
,
eczema
,
obesity
,
chronic bronchitis
,
bronchitis
,
disease progression
,
polycystic ovary syndrome
,
chronic disease
,
emphysema
,
acute disease
,
sarcoidosis
,
atherosclerosis
,
respiratory tract diseases
,
respiration disorders
,
ulcerative colitis
,
colitis
,
ulcer
,
hypersensitivity
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
heart failure
,
cardiovascular diseases
,
mortality
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use